[Hodgkin's disease with toxoplasmosis encephalitis].
D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D004660:Encephalitis / Q000209:etiology*; D005260:Female; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use; D011344:Procarbazine / Q000009:adverse effects / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000150:complications / Q000209:etiology*; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D011239:Prednisolone
Lymphogranulomatose mit Toxoplasmose-Enzephalitis